Both in Pharmaceuticals
Genprex vs Ernexa Therapeutics
Over the past year GNPX returned −98.2% and ERNA returned −95.8%; their daily moves had a correlation of -0.01.
GNPX −98.2% ERNA −95.8%Growth of $1, one year, split-adjusted
| Metric | GNPX | ERNA |
|---|---|---|
| Price | $2.24 | $1.97 |
| Market cap | $1.8M | $2.3M |
| Today | +9.80% | −6.64% |
| 1 month | −12.5% | −33.4% |
| 6 months | −88.9% | −97.9% |
| Year to date | −94.2% | −93.4% |
| 1 year | −98.5% | −95.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $15.2M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 81.6% | 79.7% |
| Short % of float | 15.3% | 2.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).